This patent covers administration of GABA producing neurons or neural stem cells from a fetus into a patient with chronic pain or spasticity. This patent covers not only human donor sources but also porcine.
The ability to generate different types of pigs through genetic engineering may allow for some of these approaches to enter the clinic. One such particular strain of pig is the alpha gal knockout, whose cells do not elicit hyperacute rejection, one of the major barriers to xenotransplantation.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.